Please Note:
This profile was automatically generated using 1 reference found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 1 reference found on the Internet. This information has not been verified. Learn more...
Employment History
View...Web References
-
1. IEEE SCV EMBS Chapter - 1999 Presentations
www.ewh.ieee.org/r6/scv/embs/p - [Cached]Published on: 12/11/2003 Last Visited: 7/8/2006
Dr. Dany Berube Fidus Medical Technology
RF ablation has been the main technology used for ablation of certain cardiac rhythm disorders since the late 1980's. This method is very efficient when the arrhythmogenic region is small and located near the endocardial surface like for the Wolff-Parkinson-White syndrome. However, when the region to ablate is large and deep, like for ventricular tachycardia, or elongated, like for atrial flutter or atrial fibrillation, the efficiency of RF ablation decreases considerably. Microwave ablation can provide better penetration of energy in the tissue and a variety of applicators can be designed using different radiation patterns to meet the specific needs of these new applications. Dr. Berube will present the basic science behind microwave ablation technology for curing cardiac arrhythmia. Highlights of animal and clinical trials will be presented.
Dany Berube received the B. Eng. degree in physical engineering from Universit of Laval in Quebec City. He received the M. ScA. and Ph.D. degrees in biomedical engineering from the Biomedical Engineering Institute of cole Polytechnique de Montral. His research interests are in dielectric property measurements of biological tissues and in the design of microwave applicators and microwave generators used to perform microwave ablation of cardiac arrhythmia. Dr. Berube is now the Director of Applied Research at Fidus Medical Technology.

